Search research articles
Contact Us
Filters
Showing results (11-20 of 432) with videos related to
Page
of 44
Sort By:
Expert Opinion on Drug Discovery
|
March 14, 2013
Considering the economic principles of pharmaceutical R&D
John A Vernon
The Journal of Physical and Colloid Chemistry
|
March 19, 2010
Colloidal aluminum oxide
A A VERNON
Journal of the Royal Society of Medicine
|
October 1, 1988
Fireworks and the eye
S A Vernon
Pharmacoeconomics
|
July 6, 2007
Perspectives on dynamic optimisation and control theory in treating hyperlipidaemia
John A Vernon
Journal of the Royal Society of Medicine
|
April 1, 1983
Analysis of all new cases seen in a busy regional centre ophthalmic casualty department during 24-week period
S A Vernon
Pharmacoeconomics
|
December 29, 2006
Letter from the Commissioner's office at the US FDA
John A Vernon
Pharmacoeconomics
|
April 4, 2007
Letter from the Commissioner's Office at the US FDA
John A Vernon
Health Economics
|
September 24, 2004
Examining the link between price regulation and pharmaceutical R&D investment
John A Vernon
Biochemical Society Transactions
|
June 1, 1984
On the catalytic factors involved in the mechanism of aspartate aminotransferase: Chairman's remarks
C A Vernon
The British Journal of Ophthalmology
|
June 1, 1995
Reproducibility with the Keeler Pulsair 2000 non-contact tonometer
S A Vernon
Page
of 44
Search research articles
Search
Showing results (11-20 of 432) with videos related to
Sort By:
Page
of 44
Expert Opinion on Drug Discovery
|
March 14, 2013
Considering the economic principles of pharmaceutical R&D
John A Vernon
The Journal of Physical and Colloid Chemistry
|
March 19, 2010
Colloidal aluminum oxide
A A VERNON
Journal of the Royal Society of Medicine
|
October 1, 1988
Fireworks and the eye
S A Vernon
Pharmacoeconomics
|
July 6, 2007
Perspectives on dynamic optimisation and control theory in treating hyperlipidaemia
John A Vernon
Journal of the Royal Society of Medicine
|
April 1, 1983
Analysis of all new cases seen in a busy regional centre ophthalmic casualty department during 24-week period
S A Vernon
Pharmacoeconomics
|
December 29, 2006
Letter from the Commissioner's office at the US FDA
John A Vernon
Pharmacoeconomics
|
April 4, 2007
Letter from the Commissioner's Office at the US FDA
John A Vernon
Health Economics
|
September 24, 2004
Examining the link between price regulation and pharmaceutical R&D investment
John A Vernon
Biochemical Society Transactions
|
June 1, 1984
On the catalytic factors involved in the mechanism of aspartate aminotransferase: Chairman's remarks
C A Vernon
The British Journal of Ophthalmology
|
June 1, 1995
Reproducibility with the Keeler Pulsair 2000 non-contact tonometer
S A Vernon
Page
of 44